Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C–Mutant Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C–Mutant Non–Small Cell Lung Cancer

Published:2021-02-08 Issue:8 Volume:27 Page:2209-2215
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Arbour Kathryn C.^ORCID,Rizvi Hira,Plodkowski Andrew J.^ORCID,Hellmann Matthew D.^ORCID,Knezevic Andrea^ORCID,Heller Glenn,Yu Helena A.,Ladanyi Marc,Kris Mark G.,Arcila Maria E.,Rudin Charles M.^ORCID,Lito Piro,Riely Gregory J.

Funder

U.S. Department of Health and Human ServicesNCINIHNCINIH

Damon Runyon Cancer Research Foundation

NIHNCINCI

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma;Pathology;2024-10

3. Efficacy of first‐line immune checkpoint inhibitor and anti‐angiogenic agent combination therapy for Kirsten rat sarcoma viral antigen‐mutant advanced non‐small‐cell lung cancer: a systematic review and network meta‐analysis;Thoracic Cancer;2024-07-31

4. Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis;Swiss Medical Weekly;2024-07-25

5. Moss-m7G: A Motif-Based Interpretable Deep Learning Method for RNA N7-Methlguanosine Site Prediction;Journal of Chemical Information and Modeling;2024-07-16